找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Critical Care of COVID-19 in the Emergency Department; Joseph R. Shiber Book 2021 The Editor(s) (if applicable) and The Author(s), under e

[复制链接]
楼主: hormone-therapy
发表于 2025-3-30 12:12:35 | 显示全部楼层
Point of Care Echocardiography in the COVID-19 Patient,ritically ill COVID-19 patient, facilitating early implementation of definitive therapy for a multitude of conditions associated with COVID-19 infection including thromboembolic disease, pleural effusion, pulmonary edema, and myocarditis. Through a protocolized approach to cleaning and disinfection,
发表于 2025-3-30 14:52:05 | 显示全部楼层
Inter-Hospital Transfer of the Critically Ill COVID-19 Patient,tinued management of these patients may exceed the capacity or capability of the hospital to which the patient presented. Inter-facility transfer of a critically ill patient with COVID-19 may therefore be necessary. Multiple models for transfer of pediatric, ST-elevation myocardial infarction, and t
发表于 2025-3-30 19:28:38 | 显示全部楼层
发表于 2025-3-30 22:06:43 | 显示全部楼层
发表于 2025-3-31 02:17:58 | 显示全部楼层
Management of Undifferentiated Critically Ill COVID-19 Patients,lly ill COVID-19 patients’ airway, breathing, and circulations (ABCs) is still paramount. This chapter reported recommendations from current literature regarding managing the undifferentiated critically ill COVID-19 patients. We also summarized our current knowledge regarding treatment for COVID-19.
发表于 2025-3-31 06:03:47 | 显示全部楼层
发表于 2025-3-31 11:25:27 | 显示全部楼层
发表于 2025-3-31 14:07:02 | 显示全部楼层
Pharmacological Agents for COVID-19 Patients,entation. Current evidence will support corticosteroids, thromboprophylaxis, and remdesivir. Limited evidence exists around the monoclonal antibodies, at this time. Some treatment options are to be initiated earlier and in higher-risk patient populations to reduce progression to more severe disease and hospitalization.
发表于 2025-3-31 19:22:13 | 显示全部楼层
发表于 2025-4-1 00:05:32 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-14 21:59
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表